Sinofert Holdings Ltd (0297)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 1.235 |
|---|---|
| 52-week range | 1.175 – 1.976 |
| Return, 1 month / 3 months | −2.4% / −4.3% |
| Return, 1 year / 3 years | −9.5% / +52.8% |
| Trend | Below its 200-day average |
| RSI (14) | 49 |
| Volatility (1 year) | 39.5% |
| Worst drawdown (1 year) | -34.1% |
| Average daily value traded | 25.59M HKD |
| Dividend yield | 5.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sinofert Holdings is a fertiliser company based in Hong Kong and operating mainly in mainland China. It makes and distributes potash, nitrogen and phosphate fertilisers, and it trades imported fertiliser materials. Its customers are farmers, agricultural cooperatives and distributors who buy crop nutrients for food and cash-crop production. The company is part of the Sinochem group of state-owned chemical businesses and also holds interests in fertiliser production ventures.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 0297, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sinofert Holdings Ltd (0297) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 1.235 on 20 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 780 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.5% and over the last three months it fell 4.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.3% | ||
| From 52-week high | -31.6% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.3% | ||
| 6-month return | -17.1% | ||
| 12-month return, skipping the last month | -7.3% | ||
| Stability (higher is calmer) | 74 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.1% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 25.59M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 58 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.6% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | +0.4% |
|---|---|
| 1 month | −2.4% |
| 3 months | −4.3% |
| 6 months | −17.1% |
| 1 year | −9.5% |
| 3 years | +52.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1.271 / 1.424 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.034 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Jun 2026 | HKD 0.0693 |
| 8 Jul 2025 | HKD 0.0246 |
| 13 Jun 2025 | HKD 0.0571 |
| 13 Jun 2024 | HKD 0.0491 |
| 23 Jun 2023 | HKD 0.0623 |
| 22 Jun 2022 | HKD 0.0528 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.